Off-Label Guide Could Prompt Re-Evaluation Of Public Presentation Policies

Washington D.C. partner Meredith Manning is quoted in the InsideHealthPolicy.com article, “Off-Label Guide Could Prompt Re-Evaluation Of Public Presentation Policies,” regarding a recent Food and Drug Administration (FDA) guidance on drug promotion and requests for off-label information. Click the link above to read the article.


Download PDF Share Back To Listing
Loading data